NCT05602701

Brief Summary

End-stage KOA results in limitations in activities of daily life (ADL), work and leisure. Treatment for KOA is a stepped care process starting with a conservative approach and in which joint replacement surgery can be considered as the last step. Total knee arthroplasty (TKA) is regarded as the gold standard for the treatment of end-stage knee osteoarthritis (KOA). In 2020, 19.501 TKA surgeries were performed in The Netherlands, end-stage KOA being (97%) the most common reason for surgery. Until now no risk inventory prediction models have been made for the prediction of physical function at six weeks after TKA. These models may help to distinguish between having a high risk or low risk on a delayed recovery of physical function at six weeks after TKA. This could be beneficial for patients with a high risk. Because than the perioperative process of this patientgroup can be optimized and improved.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2022

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 27, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 2, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

March 1, 2024

Status Verified

February 1, 2024

Enrollment Period

11 months

First QC Date

October 27, 2022

Last Update Submit

February 29, 2024

Conditions

Keywords

PreoperativeTotal Knee ArthroplastyPredictionPhysical therapyPhysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Knee injury and Osteoarthritis Outcome Score

    The Knee injury and Osteoarthritis Outcome Score (KOOS) is a knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of the knee injury. The measurement consists out of 42 items, divided in 5 domains (Pain, Symptoms, ADL, leisure and sports and QoL). The total score varies between 0-100. A higher score indicates less knee and knee associated problems.

    The KOOS is measured at 6 weeks postoperative

Study Arms (1)

Patients awaiting TKA

Patients awaiting unilateral total knee arthroplasty due to end-stage knee osteoarthritis.

Other: Preoperative assessment

Interventions

Preoperative assessment of physical fitness

Patients awaiting TKA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who are awaiting unilateral TKA and will be recruited from the orthopeadic departments from the Annadal Clinic, Zuyderland Medical Centre and Maasticht University Medical Center+.

You may qualify if:

  • Scheduled for primary unilateral TKA surgery
  • TKA surgery due to end-stage OA of the knee
  • Able to perform the preoperative assessment 4 weeks before surgery
  • Able to fulfill the KOOS by phone 6 weeks postoperatively
  • Mastery of the Dutch language

You may not qualify if:

  • Undergoing revision arthroplasty, bilateral TKA or hemi-arthroplasty surgery
  • TKA not due to KOA
  • Patients who weren't able to perform the preoperative assessment or to fulfill the KOOS postoperatively
  • Cognitive impairments
  • Complete dependence on a wheelchair
  • Unable to sign the informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Annadal Clinic

Maastricht, Limburg, 6216EG, Netherlands

Location

Maastricht University Medical Center+

Maastricht, Limburg, 6229HX, Netherlands

Location

Zuyderland Medical Centre

Sittard, Limburg, 6162BG, Netherlands

Location

Study Officials

  • Antoine F Lenssen, Prof. PhD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2022

First Posted

November 2, 2022

Study Start

October 25, 2022

Primary Completion

October 1, 2023

Study Completion

December 1, 2023

Last Updated

March 1, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

We do not intent to make IPD available to other researchers.

Locations